- Patient/Guest
- Phlebotomist
- Updates
| Glucose F and PP | - |
|---|
|
Measure fasting and postprandial glucose |
||
 |
Synonym | See updates |
 |
Test Code | CDBIOPR0005 |
 |
Test Type | Biochemistry |
 |
Pre-Test Condition | See updates |
 |
Report Availability | 1 D(s) |
 |
# Test(s) | Multiple |
| Test details | Sample Report |
|---|---|
| Glucose F and PP |
|
|
Synonym | See updates | |
|
Test Code | CDBIOPR0005 | |
 |
Test Category | Diabetes | |
|
Pre-Test Condition | See updates | |
 |
Medical History | See updates | |
|
Report Availability | 1 D(s) | |
 |
Specimen/Sample | Serum; 2 mL; SST | |
 |
Stability @21-26 deg. C | 6 Hr(s) | |
 |
Stability @ 2-8 deg. C | 7 D(s) | |
 |
Stability @ Frozen | 1 M(s) | |
|
# Test(s) | Multiple | |
 |
Processing Method | Spectrophotometry | |
| **Blood Glucose Fasting and Post Prandial 2hrs****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: Fasting and PP Glucose Test, Diabetes Profile.**Historical Breakthrough**: Developed in the 1900s to diagnose diabetes, advancing endocrinology.**Key Purpose and Impact**: Measures fasting and 2-hour postprandial glucose to diagnose diabetes or monitor glycemic control.**Preparation and Patient History**: Blood after fasting and 2 hours post-meal; report polyuria, thirst, or diabetes history.**Consent Requirement**: Standard consent for diagnostic testing.**Clinical Value**: Sensitivity ~95%; specificity ~95%; detects diabetes in ~90% of cases; guides therapy.**References Cited**: Testing.com Diabetes Tests 2023; Labcorp Glucose Test 2025; UpToDate Diabetes 2025 |